28-Mar-2024
No headlines found.
No press releases found.
No news found.
KEMX is benchmarked to the MSCI Emerging Markets ex China Index, which tracks large-cap and mid-cap companies within emerging market countries, excluding China. KEMX enables investors to build tailored EM portfolios when combined with exposure to China. KEMX can be paired with KraneShares China-focused core and thematic funds to establish strategic positions in China without duplicating exposures.
Kraneshares MSCI Emerging Markets Ex China Index ETF trades on the ARCA stock market under the symbol KEMX.
As of March 28, 2024, KEMX stock price climbed to $29.33 with 20,234 million shares trading.
KEMX has a beta of 0.87, meaning it tends to be less sensitive to market movements. KEMX has a correlation of 0.62 to the broad based SPY ETF.
KEMX has a market cap of $79.20 million. This is considered a Micro Cap stock.
In the last 3 years, KEMX stock traded as high as $33.24 and as low as $22.20.
KEMX has underperformed the market in the last year with a price return of +20.2% while the SPY ETF gained +33.6%. KEMX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.7% and 0.0%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
KEMX support price is $29.02 and resistance is $29.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KEMX stock will trade within this expected range on the day.